Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Yamaguchi, Kazunori ^a   Shiozaki, Kazuhiro ^b   Moriya, Setsuko ^c   Koseki, Koichi ^a   Wada, Tadashi ^a   Tateno, Hiroo ^d   Sato, Ikuro ^a   Asano, Masahide ^e   Iwakura, Yoichiro ^f   Miyagi, Taeko ^c  

^a MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d Surgical Pathology Japan Inc   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CARCINOGEN; DEXTRAN SULFATE; DIMETHYLHYDRAZINE; GANGLIOSIDE; NEU3 SIALIDASE; SIALIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN; CANCER INCIDENCE; CANCER MODEL; CANCER SUSCEPTIBILITY; COLITIS; COLON CARCINOGENESIS; COLON MUCOSA; COMPARATIVE STUDY; FERTILITY; GENE; MOUSE; NEU3 GENE; NONHUMAN; TUMOR GROWTH;

ANIMALS; AZOXYMETHANE; CELL MEMBRANE; COLITIS; COLONIC NEOPLASMS; DEXTRANS; GANGLIOSIDES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VECTORS; GENOTYPE; GLYCOCONJUGATES; GLYCOLIPIDS; MICE; MICE, TRANSGENIC; NEURAMINIDASE; SIALIC ACIDS; SULFATES;

MAMMALIA; MUS;

EID: 84864015437     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041132     Document Type: Article

References (61)

1. Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L, (1995) Biochemistry and role of sialic acids. In: Rosenberg A, editors. pp. 7-67 editors. Biology of the sialic acids. New York: Plenum Press.
2. Miyagi T, Yamaguchi K, (2007) Sialic acids. In: Kamerling JP, Boons G-J, editors. pp. 297-323 editors. Comprehensive Glycoscience: from chemistry to systems biology. Amsterdam; Boston: Elsevier.
3. Abercrombie M, Ambrose EJ, (1962) The surface properties of cancer cells: a review. Cancer Res 22: 525-548.
4. Miyagi T, Wada T, Yamaguchi K, Hata K, (2004) Sialidase and malignancy: a minireview. Glycoconj J 20: 189-198.
5. Varki NM, Varki A, (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 87: 851-857.
6. Monti E, Bonten E, D' Azzo A, Bresciani R, Venerando B, et al. (2010) Sialidases in vertebrates: a family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem 64: 403-479.
7. Hata K, Wada T, Hasegawa A, Kiso M, Miyagi T, (1998) Purification and characterization of a membrane-associated ganglioside sialidase from bovine brain. J Biochem 123: 899-905.
8. Miyagi T, Wada T, Iwamatsu A, Hata K, Yoshikawa Y, et al. (1999) Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J Biol Chem 274: 5004-5011.
9. Hasegawa T, Yamaguchi K, Wada T, Takeda A, Itoyama Y, et al. (2000) Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J Biol Chem 275: 8007-8015.
10. Proshin S, Yamaguchi K, Wada T, Miyagi T, (2002) Modulation of neuritogenesis by ganglioside-specific sialidase (Neu 3) in human neuroblastoma NB-1 cells. Neurochem Res 27: 841-846.
11. Aureli M, Loberto N, Lanteri P, Chigorno V, Prinetti A, et al. (2011) Cell surface sphingolipid glycohydrolases in neuronal differentiation and aging in culture. J Neurochem 116: 891-899.
12. Wang P, Zhang J, Bian H, Wu P, Kuvelkar R, et al. (2004) Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem J 380: 425-433.
13. Stamatos NM, Liang F, Nan X, Landry K, Cross AS, et al. (2005) Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. FEBS J 272: 2545-2556.
14. Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, et al. (2006) Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling. Biochem J 394: 647-656.
15. Yamaguchi K, Hata K, Wada T, Moriya S, Miyagi T, (2006) Epidermal growth factor-induced mobilization of a ganglioside-specific sialidase (NEU3) to membrane ruffles. Biochem Biophys Res Commun 346: 484-490.
16. Sasaki A, Hata K, Suzuki S, Sawada M, Wada T, et al. (2003) Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice. J Biol Chem 278: 27896-27902.
17. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, et al. (2002) Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci U S A 99: 10718-10723.
18. Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, et al. (2006) Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 281: 7756-7764.
19. Kawamura S, Sato I, Wada T, Yamaguchi K, Li Y, et al. (2011) Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling. Cell Death Differ 19: 170-179.
20. Nomura H, Tamada Y, Miyagi T, Suzuki A, Taira M, et al. (2006) Expression of NEU3 (plasma membrane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification. Oncol Res 16: 289-297.
21. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, et al. (2007) A crucial role of plasma membrane-associated sialidase in the survival of human cancer cells. Oncogene 26: 2483-2490.
22. Shiozaki K, Yamaguchi K, Sato I, Miyagi T, (2009) Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice. Cancer Sci 100: 588-594.
23. Soriano P, Montgomery C, Geske R, Bradley A, (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
24. Yagi T, Nada S, Watanabe N, Tamemoto H, Kohmura N, et al. (1993) A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal Biochem 214: 77-86.
25. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder J, (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 90: 8424-8428.
26. Asano M, Furukawa K, Kido M, Matsumoto S, Umesaki Y, et al. (1997) Growth retardation and early death of beta-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J 16: 1850-1857.
27. Sambrook J, Fritsch E, Maniatis T, (2001) Molecular Cloning: A Laboratory Manual. New York, USA: Cold Spring Harbor Laboratory Press, NY.
28. Shiozaki K, Koseki K, Yamaguchi K, Shiozaki M, Narimatsu H, et al. (2009) Developmental change of sialidase neu4 expression in murine brain and its involvement in the regulation of neuronal cell differentiation. J Biol Chem 284: 21157-21164.
29. Tudek B, Bird RP, Bruce WR, (1989) Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res 49: 1236-1240.
30. Neufert C, Becker C, Neurath MF, (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2: 1998-2004.
31. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, et al. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94: 965-973.
32. Euhus DM, Hudd C, LaRegina MC, Johnson FE, (1986) Tumor measurement in the nude mouse. J Surg Oncol 31: 229-234.
33. Tomayko MM, Reynolds CP, (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148-154.
34. Comelli EM, Amado M, Lustig SR, Paulson JC, (2003) Identification and expression of Neu4, a novel murine sialidase. Gene 321: 155-161.
35. Yamaguchi K, Hata K, Koseki K, Shiozaki K, Akita H, et al. (2005) Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J 390: 85-93.
36. Valaperta R, Chigorno V, Basso L, Prinetti A, Bresciani R, et al. (2006) Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J 20: 1227-1229.
37. Bird RP, (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93: 55-71.
38. Bird RP, Good CK, (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112-113: 395-402.
39. Matkowskyj KA, Marrero JA, Carroll RE, Danilkovich AV, Green RM, et al. (1999) Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. Am J Physiol 277: G455-G462.
40. Zhu H, Dougherty U, Robinson V, Mustafi R, Pekow J, et al. (2011) EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators. Mol Cancer Res 9: 960-975.
41. Schetter AJ, Heegaard NH, Harris CC, (2010) Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31: 37-49.
42. Karin M, (2009) NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1: a000141.
43. Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40.
44. Katoh S, Miyagi T, Taniguchi H, Matsubara Y, Kadota J, et al. (1999) Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes. J Immunol 162: 5058-5061.
45. Katoh S, Maeda S, Fukuoka H, Wada T, Moriya S, et al. (2010) A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model. Clin Exp Immunol 161: 233-241.
46. Finlay TM, Abdulkhalek S, Gilmour A, Guzzo C, Jayanth P, et al. (2010) Thymoquinone-induced Neu4 sialidase activates NFκB in macrophage cells and pro-inflammatory cytokines in vivo. Glycoconj J 27: 583-600.
47. Witz IP, (2008) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100: 203-229.
48. Auger KR, Wang J, Narsimhan RP, Holcombe T, Roberts TM, (2000) Constitutive cellular expression of PI 3-kinase is distinct from transient expression. Biochem Biophys Res Commun 272: 822-829.
49. Hann A, Gruner A, Chen Y, Gress TM, Buchholz M, (2011) Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells. PLoS One 6: e20859.
50. Hahn WC, Weinberg RA, Hahn WC, Weinberg RA, (2002) Modelling the molecular circuitry of cancer. Nature Reviews Cancer 2: 331.
51. Markiewski MM, Lambris JD, (2009) Is complement good or bad for cancer patients? A new perspective on an old dilemma. Trends Immunol 30: 286-292.
52. Steinmann KE, Belinsky GS, Lee D, Schlegel R, (1991) Chemically induced premature mitosis: differential response in rodent and human cells and the relationship to cyclin B synthesis and p34cdc2/cyclin B complex formation. Proc Natl Acad Sci U S A 88: 6843-6847.
53. Wright WE, Shay JW, (2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 6: 849-851.
54. Rangarajan A, Hong SJ, Gifford A, Weinberg RA, (2004) Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6: 171-183.
55. Wada T, Yoshikawa Y, Tokuyama S, Kuwabara M, Akita H, et al. (1999) Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun 261: 21-27.
56. Miyagi T, Yamaguchi K, (2012) Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology doi:10.1093/glycob/cws057.
57. de Geest N, Bonten E, Mann L, de Sousa-Hitzler J, Hahn C, et al. (2002) Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 11: 1455-1464.
58. Seyrantepe V, Canuel M, Carpentier S, Landry K, Durand S, et al. (2008) Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage. Hum Mol Genet 17: 1556-1568.
59. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, et al. (2002) A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 277: 26252-26259.
60. Papini N, Anastasia L, Tringali C, Croci G, Bresciani R, et al. (2004) The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions. J Biol Chem 279: 16989-16995.
61. Yogalingam G, Bonten EJ, van de Vlekkert D, Hu H, Moshiach S, et al. (2008) Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 15: 74-86.